NASDAQ: MYGNMyriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?
Insider buying vs selling
Have Myriad Genetics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Benjamin Richard Wheeler | CFO | 2026-08-16 | 8,761 | $3.03 | $26.55kSell |
| Samraat S. Raha | President and CEO | 2026-06-11 | 3,542 | $3.94 | $13.94kBuy |
| Brian J. Donnelly | Chief Commerical Officer | 2026-06-11 | 5,000 | $3.94 | $19.68kBuy |
| Rashmi Kumar | Director | 2026-06-08 | 15,000 | $4.46 | $66.84kSell |
| Paul Bisaro | Director | 2026-05-14 | 7,500 | $3.69 | $27.64kBuy |
| Brian J. Donnelly | Chief Commerical Officer | 2026-05-01 | 55,975 | $4.80 | $268.68kSell |
| Mark Verratti | Chief Operating Officer | 2026-04-14 | 1,069 | $4.91 | $5.25kSell |
| Dale Muzzey | Chief Scientific Officer | 2026-04-14 | 946 | $4.91 | $4.64kSell |
| Dale Muzzey | Chief Scientific Officer | 2026-03-22 | 2,019 | $4.58 | $9.25kSell |
| Benjamin Richard Wheeler | Chief Financial Officer | 2026-03-22 | 549 | $4.58 | $2.51kSell |
MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MYGN insiders and whales buy or sell their stock.
MYGN Shareholders
What type of owners hold Myriad Genetics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Samraat S. Raha | 1.12% | 1,068,083 | $3.42M | Insider |
| Paul J. Diaz | 0.93% | 891,844 | $2.85M | Insider |
| Mark H. Skolnick | 0.80% | 764,724 | $2.45M | Insider |
| Mark Verratti | 0.66% | 629,646 | $2.01M | Insider |
| Brian J. Donnelly | 0.60% | 573,363 | $1.83M | Insider |
| Mark Christopher Capone | 0.55% | 522,216 | $1.67M | Insider |
| S. Louise Phanstiel | 0.39% | 374,771 | $1.20M | Insider |
| Dale Muzzey | 0.34% | 326,310 | $1.04M | Insider |
| Jennifer Lynne Fox | 0.32% | 310,362 | $993.16k | Insider |
| Richard Bryan Riggsbee | 0.31% | 291,812 | $933.80k | Insider |
MYGN vs Diagnostic & Research Stocks
Myriad Genetics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.